Functional haplotypes in the promoter region of transcription factor Nrf2 in chronic obstructive pulmonary disease

Disease Markers

Volumn 28, Issue 3, 2010, Pages 185-193

  Hua, Chung Ching ^a   Chang, Liang Che ^a   Tseng, Jo Chi ^a   Chu, Chien Ming ^a   Liu, Yu Chih ^a   Shieh, Wen Bin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

COPD; haplotype; Nrf2; promoter; Respiratory failure

Indexed keywords

DNA; LUCIFERASE; TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HAPLOTYPE; HAZARD RATIO; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY FAILURE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77954124777     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0700     Document Type: Article

References (40)

1. P. Kirkham and I. Rahman, Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy, Pharmacol Ther 111 (2006), 476-494.
2. I. Rahman and I.M. Adcock, Oxidative stress and redox regulation of lung inflammation in COPD, Eur Respir J 28 (2006), 219-242.
3. T. Rangasamy, C.Y. Cho, R.K. Thimmulappa, L. Zhen, S.S. Srisuma, T.W.Kensler, M.Yamamoto, I. Petrache, R.M.Tuder and S. Biswal, Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice, J Clin Invest 114 (2004), 1248-1259.
4. K. Itoh, K. Igarashi, N. Hayashi, M. Nishizawa and M. Yamamoto, Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins, Mol Cell Biol 15 (1995), 4184-4193.
5. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel and M. Yamamoto, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev 13 (1999), 76-86.
6. H. Motohashi and M. Yamamoto, Nrf2-Keap1 defines a physiologically important stress response mechanism, Trends Mol Med 10 (2004), 549-557.
7. H.Y. Cho, S.P. Reddy, A. Debiase, M. Yamamoto and S.R. Kleeberger, Gene expression profiling of NRF2-mediated protection against oxidative injury, Free Radic Biol Med 38 (2005), 325-343. (Pubitemid 40081112)
8. D. Goven, A. Boutten, V. Lecon-Malas, J. Marchal-Somme, N. Amara, B. Crestani, M. Fournier, G. Leseche, P. Soler, J. Boczkowski and M. Bonay, Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema, Thorax 63 (2008), 916-924.
9. D. Malhotra, R. Thimmulappa, A. Navas-Acien, A. Sandford, M. Elliott, A. Singh, L. Chen, X. Zhuang, J. Hogg, P. Pare, R.M. Tuder and S. Biswal, Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1, Am J Respir Crit Care Med 178 (2008), 592-604.
10. A. Singh, G. Ling, A.N. Suhasini, P. Zhang, M. Yamamoto, A. Navas-Acien, G. Cosgrove, R.M. Tuder, T.W. Kensler, W.H. Watson and S. Biswal, Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs, Free Radic Biol Med 46 (2009), 376-386.
11. M. Suzuki, T. Betsuyaku, Y. Ito, K. Nagai, Y. Nasuhara, K. Kaga, S. Kondo and M. Nishimura, Down-regulated NF-E2- related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol 39 (2008), 673-682.
12. S. Pierrou, P. Broberg, R.A. O'Donnell, K. Pawlowski, R. Virtala, E. Lindqvist, A. Richter, S.J.Wilson, G. Angco, S. Moller, H. Bergstrand, W. Koopmann, E.Wieslander, P.E. Stromstedt, S.T. Holgate, D.E. Davies, J. Lund and R. Djukanovic, Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease, Am J Respir Crit Care Med 175 (2007), 577-586.
13. I. Rahman and W. MacNee, Role of oxidants/antioxidants in smoking-induced lung diseases, Free Radic Biol Med 21 (1996), 669-681.
14. T.E. Sussan, T. Rangasamy, D.J. Blake, D. Malhotra, H. El- Haddad, D. Bedja, M.S. Yates, P. Kombairaju, M. Yamamoto, K.T. Liby, M.B. Sporn, K.L. Gabrielson, H.C. Champion, R.M. Tuder, T.W. Kensler and S. Biswal, Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice, Proc Natl Acad Sci U S A 106 (2009), 250-255.
15. S.K. Biswas and I. Rahman, Environmental toxicity, redox signaling and lung inflammation: the role of glutathione, Mol Aspects Med 30 (2009), 60-76.
16. T. Yamamoto, K. Yoh, A. Kobayashi, Y. Ishii, S. Kure, A. Koyama, T. Sakamoto, K. Sekizawa, H. Motohashi and M. Yamamoto, Identification of polymorphisms in the promoter region of the human NRF2 gene, Biochem Biophys Res Commun 321 (2004), 72-79. (Pubitemid 39055607)
17. J.M. Marzec, J.D. Christie, S.P. Reddy, A.E. Jedlicka, H. Vuong, P.N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H.Y. Cho and S.R. Kleeberger, Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury, FASEB J 21 (2007), 2237-2246.
18. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel and J. Zielinski, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med 176 (2007), 532-555.
19. Standardization of Spirometry, 1994 Update. American Thoracic Society, Am J Respir Crit Care Med 152 (1995), 1107-1136.
20. Guidelines for the use of ILO international classification of radiographs of pneumoconiosis, Series 22, 1981.
21. H.N. Shen, J.S. Jerng, C.J. Yu and P.C. Yang, Outcome of coal worker's pneumoconiosis with acute respiratory failure, Chest 125 (2004), 1052-1058.
22. A.N. Vallejo, R.J. Pogulis and L.R. Pease, Mutagenesis and synthesis of novel recombinant genes using PCR, in: PCR Primer: a Laboratory Manual, C.W. Dieffenbach and G.S. Dveksler, eds, Cold Spring Harbor Laboratory Press, New York, 2003, pp. 467-474.
23. V.N. Venables and B.D. Ripley, Modern Applied Statistics With S, (4th ed.), Springer, New Yoirk, 2002, pp. 175-176.
24. H.Y. Cho and S.R. Kleeberger, Genetic mechanisms of susceptibility to oxidative lung injury in mice, Free Radic Biol Med 42 (2007), 433-445.
25. I. Rahman and W. MacNee, Role of transcription factors in inflammatory lung diseases, Thorax 53 (1998), 601-612.
26. P.J. Barnes, I.M. Adcock and K. Ito, Histone acetylation and deacetylation: importance in inflammatory lung diseases, Eur Respir J 25 (2005), 552-563. (Pubitemid 40331188)
27. Z. Kluchova, D. Petrasova, P. Joppa, Z. Dorkova and R. Tkacova, The association between oxidative stress and obstructive lung impairment in patients with COPD, Physiol Res 56 (2007), 51-56.
28. P. Ghezzi, V. Bonetto and M. Fratelli, Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation, Antioxid Redox Signal 7 (2005), 964-972.
29. H.J. Forman, J.M. Fukuto and M. Torres, Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers, Am J Physiol Cell Physiol 287 (2004), C246-C256.
30. K.M. Beeh, J. Beier, N. Koppenhoefer and R. Buhl, Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD, Chest 126 (2004), 1116-1122.
31. Y. Ishii, K. Itoh, Y. Morishima, T. Kimura, T. Kiwamoto, T. Iizuka, A.E. Hegab, T. Hosoya, A. Nomura, T. Sakamoto, M. Yamamoto and K. Sekizawa, Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema, J Immunol 175 (2005), 6968-6975.
32. S.G. Kelsen, X. Duan, R. Ji, O. Perez, C. Liu and S. Merali, Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach, Am J Respir Cell Mol Biol 38 (2008), 541-550.
33. T.L. Adair-Kirk, J.J. Atkinson, G.L. Griffin, M.A. Watson, D.G. Kelley, D. DeMello, R.M. Senior and T. Betsuyaku, Distal airways in mice exposed to cigarette smoke: Nrf2- regulated genes are increased in Clara cells, Am J Respir Cell Mol Biol 39 (2008), 400-411.
34. K. Usdin, The biological effects of simple tandem repeats: lessons from the repeat expansion diseases, Genome Res 18 (2008), 1011-1019.
35. B.B. Tuch, H. Li and A.D. Johnson, Evolution of eukaryotic transcription circuits, Science 319 (2008), 1797-1799.
36. I. Rahman, Antioxidant therapeutic advances in COPD, Ther Adv Respir Dis 2 (2008), 351-374.
37. J.D. Hayes and M. McMahon, NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer, Trends Biochem Sci 34 (2009), 176-188.
38. E. Sapey and R.A. Stockley, COPD exacerbations. 2: aetiology, Thorax 61 (2006), 250-258.
39. E.M. Drost, K.M. Skwarski, J. Sauleda, N. Soler, J. Roca, A. Agusti and W. MacNee, Oxidative stress and airway inflammation in severe exacerbations of COPD, Thorax 60 (2005), 293-300.
40. T. Strachan and A.P. Read, Human Molecular Genetics, (3rd ed.), Garland Science, New York, 2004, pp. 275-314.